Literature DB >> 9987158

Homing potentials of circulating antibody-secreting cells after administration of oral or parenteral protein or polysaccharide vaccine in humans.

A Kantele1, M Westerholm, J M Kantele, P H Mäkelä, E Savilahti.   

Abstract

The site of antigen encounter influences the Ig-distribution and homing potentials of circulating antibody-secreting cells (ASC) induced. After oral antigen administration, the majority ASC secrete the mucosal Ig-isotype, IgA, and all of them express the gut homing receptor (HR), alpha 4 beta 7, thus implying mucosal homing of these cells. Parenteral protein vaccine induces an IgG-dominated response with a low proportion of alpha 4 beta 7 expressing cells. However, a polysaccharide vaccine, even if administered parenterally, elicits an IgA-dominated response, hence suggesting homing to the mucosa. In order to study the influence of the nature of the antigen on the targeting of the ASC response, the present work compares the homing potentials of circulating ASC in humans after administration of an oral Salmonella Typhi Ty21a vaccine (antigen studied: O-9,12 polysaccharide), an oral recombinant cholera vaccine (antigen studied: cholera toxin B-subunit, CTB protein), a parenteral pneumococcal vaccine (antigen studied: Pnc capsular polysaccharide 19F) or a parenteral tetanus toxoid vaccine (antigen studied: TT protein). alpha 4 beta 7 was expressed on a higher proportion of ASC induced by oral O-9,12 (99%) and CTB (99%) than by parenteral Pnc (70%) or TT (63%). L-selectin, the peripheral lymph node HR, was expressed on a smaller proportion of ASC induced by O-9,12 (37%) or CTB (43%) than of those induced by Pnc (78%) or TT (81%). The results imply that even if the nature of the antigen has a profound effect on the Ig-distribution of the ASC response, it does not seem to influence the targeting of the response.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9987158     DOI: 10.1016/s0264-410x(98)00193-5

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  14 in total

1.  Expression of homing receptors on IgA1 and IgA2 plasmablasts in blood reflects differential distribution of IgA1 and IgA2 in various body fluids.

Authors:  Sari H Pakkanen; Jussi M Kantele; Zina Moldoveanu; Spencer Hedges; Miikka Häkkinen; Jiri Mestecky; Anu Kantele
Journal:  Clin Vaccine Immunol       Date:  2010-01-20

Review 2.  Role of retinoic acid in the imprinting of gut-homing IgA-secreting cells.

Authors:  J Rodrigo Mora; Ulrich H von Andrian
Journal:  Semin Immunol       Date:  2008-09-18       Impact factor: 11.130

3.  Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines.

Authors:  Sanae Sasaki; Maria C Jaimes; Tyson H Holmes; Cornelia L Dekker; Kutubuddin Mahmood; George W Kemble; Ann M Arvin; Harry B Greenberg
Journal:  J Virol       Date:  2006-10-18       Impact factor: 5.103

4.  Live oral typhoid vaccine Ty21a induces cross-reactive humoral immune responses against Salmonella enterica serovar Paratyphi A and S. Paratyphi B in humans.

Authors:  Rezwanul Wahid; Raphael Simon; Shah J Zafar; Myron M Levine; Marcelo B Sztein
Journal:  Clin Vaccine Immunol       Date:  2012-04-04

5.  Maturation and trafficking markers on rotavirus-specific B cells during acute infection and convalescence in children.

Authors:  María C Jaimes; Olga L Rojas; Eric J Kunkel; Nicole H Lazarus; Dulce Soler; Eugene C Butcher; Dorsey Bass; Juana Angel; Manuel A Franco; Harry B Greenberg
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

6.  Beta7-integrin-independent enhancement of mucosal and systemic anti-HIV antibody responses following combined mucosal and systemic gene delivery.

Authors:  Amanda Goodsell; Fengmin Zhou; Soumi Gupta; Manmohan Singh; Padma Malyala; Jina Kazzaz; Catherine Greer; Harold Legg; Tony Tang; January Zur Megede; Ranjana Srivastava; Susan W Barnett; John J Donnelly; Paul A Luciw; John Polo; Derek T O'Hagan; Michael Vajdy
Journal:  Immunology       Date:  2007-10-17       Impact factor: 7.397

7.  Safety and efficacy of low dose Escherichia coli enterotoxin adjuvant for urease based oral immunisation against Helicobacter pylori in healthy volunteers.

Authors:  S Banerjee; A Medina-Fatimi; R Nichols; D Tendler; M Michetti; J Simon; C P Kelly; T P Monath; P Michetti
Journal:  Gut       Date:  2002-11       Impact factor: 23.059

8.  Induction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations.

Authors:  Anthony D Cristillo; Maria Grazia Ferrari; Lauren Hudacik; Brad Lewis; Lindsey Galmin; Britany Bowen; DeVon Thompson; Nikolai Petrovsky; Phillip Markham; Ranajit Pal
Journal:  J Gen Virol       Date:  2011-01       Impact factor: 3.891

9.  Persistence of diarrheal pathogens is associated with continued recruitment of plasmablasts in the circulation.

Authors:  Anu Kantele
Journal:  Clin Dev Immunol       Date:  2012-01-19

10.  Head-to-head comparison of humoral immune responses to Vi capsular polysaccharide and Salmonella Typhi Ty21a typhoid vaccines--a randomized trial.

Authors:  Anu Kantele; Sari H Pakkanen; Riitta Karttunen; Jussi M Kantele
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.